PitchBook is a financial technology company that provides data on the capital markets. A Look Back at the Past Decade of European Biotech. NHSA […] Portfolio Holdings . CLÍNICA UNIVERSIDAD DE NAVARRA Novo Gene. Oxford Nanopore Technologies (UK) Founders: Gordon Sanghera, Hagan Bayley Valuation: £1.5 billion Total Funding: €529 million Founded Year: 2005. A British company, number 32 on our list of the 50 Smartest Companies, bets a tiny analyzer will change how we look at DNA. View Company. Oxford Nanopore has stated that the most recent round of funding will be used to build a factory in Oxfordshire that will enable the company to meet the growing demand for its sequencing … Background The NHSA began working with Oxford Nanopore Technologies as the company was interested in looking at clinical applications of their MinION device. Today, Oxford Nanopore Technologies is the only company to have brought nanopore-based sequencers to market. Undeterred by competitors, Oxford Nanopore, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next-generation sequencing platform. Oxford Nanopore Technologies has raised $975.47 m in total funding. Get the full list », You’re viewing 5 of 18 investors. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. Personalize which data points you want to see and create visualizations instantly. I wrote this article myself, and it expresses my own opinions. Get the full list », You’re viewing 5 of 9 executive team members. Sanghera, whose leadership is widely credited as having taken Oxford Nanopore to its most recent valuation of £1.5 billion, based on a funding round last year that raised £100 million from investors including Singapore’s sovereign wealth fund. By Iain Gilbert. Oxford Nanopore Technologies. Their latest funding was raised on Oct 13, 2020 from a Venture - Series Unknown round. That brings us to the next point that the asking price of $2B for Oxford Nanopore is too high. Oxford Nanopore Technologies has raised a total of £754.2M in funding over 17 rounds. Can the company's $1.5bn valuation be justified when last year it took just $23.5m in orders? OXFORD NANOPORE TECHNOLOGIES LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity. During the period of the LF Woodford Equity Income Fund’s suspension and subsequent repositioning of its portfolio, we will only be showing the top 10 holdings of our three funds, and no detailed commentary on each holding. Oxford Nanopore recently announced that it has attracted a further £100M in funding. Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis by making high performance, novel DNA/RNA sequencing technology that is accessible and easy to use. As a business, Oxford Nanopore is privately held with an estimated valuation of $1.57 billion. Macrogen. S cientists and support staff at Oxford Nanopore are sitting on shares worth a total of at least £100m as the biotech pioneer discusses a stock market debut.. Oxford Nanopore are now nipping at Illumina’s heels along with Qiagen (see my recent post on the Genereader sequencer)and PacBio. We can argue in three ways. The Good News from Oxford Nanopore that exposes the valuation scandal at Woodford. The company’s flagship MinION device has been challenging competitors with its ability to sequence an entire human genome using protein nanopores to sequence DNA in real time with high accuracy. The Good News from Oxford Nanopore that exposes the valuation scandal at Woodford. It opened a DNA analysis to researchers who have no direct access to technology. Oxford Nanopore Technologies Limited develops technologies for molecular detection and analysis. What Does the Next Decade Have in Store for European Biotech? Last year, Amgen a California based biotech, acquired a 3% stake in the gene analysis company in a deal in which Oxford Nanopore was valued at £1.5 billion. Oxford Nanopore's valuation hits £1.5bn after Asia-Pac funding round La Clínica Universidad de Navarra comienza a utilizar un nuevo catéter. Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis by making high performance, novel DNA/RNA sequencing technology that is accessible and easy to use. Oxford Nanopore’s Hand-Held DNA Analyzer Has Traveled the World. PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Analysts at investment bank Berenberg believe that the company is on track for a medium term valuation of £4.5 billion to £7 billion. The developer of the pocket-sized MinION real-time DNA/RNA sequencer and other nanopore analysis devices said the funds will support its next … WuXi AppTec. It is not known what value Oxford Nanopore will get as a listed company. Stellar commercial and technical success of the UK based nucleic acid analysis company indicates it can go public on a higher valuation. Oxford Nanopore's valuation hits £1.5bn after Asia-Pac funding round La Clínica Universidad de Navarra comienza a utilizar un nuevo catéter. PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. Berry Genomics. Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis by making high performance, novel DNA/RNA sequencing technology that is accessible and easy to use. Contact Get started. “Discounting to today implies a $6-billion valuation, but we discount by 67% to account for the lack of data, or commercial launch, and the company's small size. Oxford Nanopore’s Hand-Held DNA Analyzer Has Traveled the World. The company has developed a nanopore DNA sequencing platform that is uniquely scalable from pocket-sized formats through to ultra-high-throughput devices, thereby offering researchers with real-time data analysis for rapid and dynamic insights. Want the latest in European biotech delivered straight to your inbox? Our data for Oxford Nanopore usage goes back as far as 1 years and 7 months. Oxford Nanopore. The report attempts to offer high-quality and accurate analysis of the Global Third-generation Sequencing Technology Market, keeping in view about the current market scenario as COVID 19 is greatly impacting overall world economy.It also focuses on competitive intelligence, and technological risks and advancements, and other important subjects. ADVERTISEMENT. Welcome to Oxford Nanopore technologies. We can argue in three ways. Pacbio, BGI), it is impossible to come up with anything more that $700M-$800M. … Hope you’ll enjoy reading our stories! As DNA passes through the nanopore, it causes changes in current which can be detected and used to sequence the DNA. Oxford Nanopore, the disruptive unicorn gunning for Illumina. The privately held, UK-based firm said it raised £29.3 million in capital and sold £80.2 million in shares. All of these technologies currently do not deliver the Q30+ data Illumina have bet the farm on – the next 18 months will be interesting as we see if users are prepared to switch to “lower quality” raw sequencing, for “higher quality” results. 19th - 21st May 2021 . About Oxford Nanopore Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis by making high performance, novel DNA/RNA sequencing technology that is accessible and easy to use. All of these technologies currently do not deliver the Q30+ data Illumina have bet the farm on – the next 18 months will be interesting as we see if users are prepared to switch to “lower quality” raw sequencing, for “higher quality” results. Oxford Nanopore Technologies valuation is $1.6 b, and annual revenue was £32.52 m in FY 2018. Evaluation of Oxford Nanopore’s MinION Sequencing Device for Microbial Whole Genome Sequencing Applications. Do you like it? Companies House Companies House does not verify the accuracy of the information filed (link opens a new window) Sign in / Register. Get started Talk to us Subscribe. Oxford Nanopore Technologies has raised a total of £754.2M in funding over 17 rounds. Oxford Nanopore Technologies has 477 employees across 9 locations, $975.47 m in total funding, and £32.52 M in annual revenue in FY 2018. January 11, 2017. According to our sources, Oxford Nanopore’s valuation is currently at an impressive £1.5Bn (€1,71Bn). Its success can be attributed to its fast, pocket-sized devices and their potential applications in the clinical diagnostics market. Images by  Double Brain, anyaivanova/Shutterstock. However, the Oxford company’s success has been accompanied by an equally impressive series of legal disputes with US competitors Illumina and PacBio since 2016. Get the full list », Co-Founder, Chief Executive Officer & Board Member, Co-Founder, Chief Business Development Officer & Board Member. Oxford Nanopore Technologies Fully scalable, real-time DNA/RNA sequencing technology Oxford Nanopore Diagnostics LamPORE – rapid, low-cost, scalable detection of SARS-CoV-2 London Calling 2021 online A conference dedicated to scientific research using nanopore … In 2016, Oxford Nanopore Technologies secured a whopping €120M — the largest in Europe that year. The privately held, UK-based firm said it raised £29.3 million in capital and sold £80.2 million in shares. Use the PitchBook Platform to explore the full profile. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Oxford Nanopore Technologies is funded by 14 investors. July 2018 ; Scientific Reports 8(1) DOI: 10.1038/s41598-018-29334-5. Register to attend. This is a portable, real time, long read and low cost device that has opened up DNA sequencing to researchers who would never normally have access to this kind of technology. A British company, number 32 on our list of the 50 Smartest Companies, bets … May 23, 2017. These . Why its hot: Oxford Nanopore Technologies works with the goal to disrupt the paradigm of biological analysis. Oxford Nanopore, the gene analysis company, has told investors it plans a stock market listing within 12 months, handing a lifeline to fund manager … Oxford Nanopore Technologies Limited develops technologies for molecular detection and analysis. Others : Global DNA Next Generation Sequencing Market Report Scope: Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. Handheld Device Sequences Human Genome. Kaarmann, TransferWise’s chief executive, was among those in attendance. Oxford Nanopore Valuation is Too High. Oxford Nanopore. In our opinion, the cost of bringing this promising technology to the market had been too high and may not be ultimately supported by the market. Oxford Nanopore is the principal driver of IPO’s valuation: IP Group’s 19.7% stake in Oxford Nanopore is valued at £246.3 million, or 18% of the total portfolio. Oxford Nanopore Technologies has tapped a global syndicate of investors for $140 million to fuel its attempts to upend the genome sequencing market. By Tom Winnifrith | Tuesday 20 March 2018. In 2018, revenues surged to £32.5m, up from £13.8m the previous year. First, if you compare the current revenues and profits of Oxford Nanopore with … Oxford Nanopore Technologies is funded by 14 investors. By Tom Winnifrith | Tuesday 20 March 2018. There are concerns, though, that its $1.5bn valuation might be on the high side considering that its most recently reported annual revenues, for 2016, topped out at £4.5m ($6.4m) and its … Oxford Nanopore are now nipping at Illumina’s heels along with Qiagen (see my recent post on the Genereader sequencer)and PacBio. OXFORD NANOPORE TECHNOLOGIES LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity If Oxford Nanopore can deliver this forecasted revenue, Numis argues that the market could pay over 25x forward earnings, placing a valuation on the company in four years of nearly $10 billion. According to our sources, Oxford Nanopore’s valuation is currently at an impressive £1.5Bn (€1,71Bn). Oxford Nanopore, the largest unquoted ... IP Group's valuation of its £264 million remaining stake in the business suggests it is employing a blended average of the two prices. The Oxford … I am not receiving compensation for it (other than from ShareProphets). Last year the start-up lost £53.1 million on revenues of £32.5 million. Read more. Last year, Amgen a California based biotech, acquired a 3% stake in the gene analysis company in a deal in which Oxford Nanopore was valued at £1.5 billion. We firmly believe this is in the best interests of investors. IP Group remains the company’s largest shareholder with a stake of 18.3%. Developer of a new generation of DNA/RNA sequencing technology designed to enable the analysis of any living thing, by a. ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. That was, however, an improvement on 2017 losses of £56.5 million. However, several other companies are developing their own technology, and Oxford Nanopore may not be the only supplier of nanopore-based sequencers much longer. Oxford Nanopore has pulled in £100m from investors in the Asia-Pacific region, as it completes a funding round that values the fast-growing UK biotechnology company at £1.5bn. Oxford Nanopore was spun-out from Oxford University as a private company in 2005 but is still loss making. Snippet roundup: Funding boosts the US NIH and could spawn a UK ubercorn. The Company offers technologies that are used in … This included Deliveroo, Oxford Nanopore and Revolut – as part of a charm offensive to sell the City’s credentials to the sector. NEW YORK – Oxford Nanopore Technologies said Thursday it has raised a total of £109.5 million ($144.4 million) between new capital investments and the sale of secondary shares. See insights on Oxford Nanopore Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Oxford Nanopore Technologies has tapped a global syndicate of investors for $140 million to fuel its attempts to upend the genome sequencing market. Oxford Nanopore has worked to establish the concept of an 'Internet of Living Things', originally conceived as an 'Internet of DNA' by David Haussler, a bioinformatician based at UC Santa Cruz. This is not the first significant fundraising round for the company. CLÍNICA UNIVERSIDAD DE NAVARRA Oxford Nanopore Technologies has been hailed as one of Britain’s most promising unicorns, a private company worth more than $1 billion. All rights reserved. Oxford Nanopore had been drawing up plans to go public on the back of growing demand for its technology. One may counterargue based … GIC, Others Invest £100m In Hand-held DNA Sequencing firm Oxford Nanopore. The company plans to use its new funding to expand its genome sequencing product line to address the real-time genetic analysis of infectious diseases, food and water surveillance, and large-scale, on-demand sequencing of plant and animal genomes in addition to human. Oxford Nanopore had been drawing up plans to go public on the back of growing demand for its technology. For various reasons explained in our earlier blog posts, we have been negative on the company. The last funding round of $136 million closed just last month, giving Oxford Nanopore a valuation of $1.55 billion, and landing them on the highly coveted CB Insights Unicorn List . In 2018, revenues surged to £32.5m, up from £13.8m the previous year. Oxford Nanopore's valuation hits £1.5bn after Asia-Pac funding round. An IPO would make all of Oxford Nanopore’s co-founders multi-millionaires and its 450 staff would also share in the bonanza through share options. Our goal is to enable the analysis of any living thing, by any person, in any environment. The latest investment round values Oxford Nanopore at £1.5B, with Singapore-based GIC, China Construction Bank International and Australian company Hostplus contributing to the offer. Oxford Nanopore Technologies said it has raised £100 million ($140 million) in new financing, with plans to use the proceeds toward commercial expansion efforts, including a new manufacturing facility, and the development of new products. Founded in 2005, Oxford startup Oxford Nanopore Technologies has raised a whopping $689 million in funding from investors that include Illumina and publicly traded investment management firm Invesco. Labiotech.eu is the leading digital media covering the European Biotech industry. This valuation seems somewhat at odds with the group’s financial performance. The last funding round of $136 million closed just last month, giving Oxford Nanopore a valuation of $1.55 billion, and landing them on the highly … Oxford Nanopore Technologies: Worth £930m at its most recent fund-raising. Stellar commercial and technical success of the UK based nucleic acid analysis company indicates it can go public on a higher valuation. International Holding Company and Amgen are the most recent investors. Despite the aggressive behavior of its competitors, Oxford Nanopore is the only company in the world being able to rival with Illumina in the sequencing market. Skip to main content. However, apart from having to change the molecular mechanism of one of its sequencing products Oxford Nanopore has not suffered major repercussions. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. Date: Tuesday 20 Mar 2018 (ShareCast News) - Biotech firm Oxford Nanopore has raised £100m from its latest private funding round, valuing the rapidly-expanding UK group somewhere in the vicinity of £1.5bn as a result. Oxford Nanopore was valued at a reported £1.5 billion in March 2018 with a £100 million investment from GIC, China Construction Bank International and Australian superannuation fund Hostplus, among others. © 2021 PitchBook Data. Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. With the latest round of financing cementing its unicorn status and a new benchtop sequencing system having hit the market at the end of last year, Oxford Nanopore Technologies is sitting pretty. ... Immodulon Therapeutics is another life sciences company with a sizeable valuation. In 2016, Oxford Nanopore Technologies secured a whopping €120M — the largest in Europe that year. Covid-19 Vaccines Roll Out in the UK and EU: What’s Next? March 23, 2018. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast … For example, a fast genome sequencing method could help track how viral infections evolve drug resistance. Oxford Nanopore Technologies Fully scalable, real-time DNA/RNA sequencing technology Oxford Nanopore Diagnostics LamPORE – rapid, low-cost, scalable detection of SARS-CoV-2 London Calling 2021 online A conference dedicated to scientific research using nanopore DNA/RNA sequencing. We have data on 193 companies that use Oxford Nanopore. [ citation needed ] In an article in Wired in 2015, Clive Brown, CTO of Oxford Nanopore noted that "future nanopore sensing devices linked to cloud based analyses could run anywhere on anything. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION. Hostplus Sinks $27m Into Hand-held DNA Sequencing Firm Oxford Nanopore. All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation. Developer of a new generation of DNA/RNA sequencing technology designed to enable the analysis of any living thing, by any person, in any environment. That brings us to the next point that the asking price of $2B for Oxford Nanopore is too high. Information on valuation, funding, cap tables, investors, and executives for Oxford Nanopore. Online. The companies using Oxford Nanopore are most often found in United States and in the Higher Education industry. Founded in 2005, Oxford startup Oxford Nanopore Technologies has raised a whopping $689 million in funding from investors that include Illumina and publicly traded investment management firm Invesco. For example, Two Pore Guys has announced the release of its product suite in spring 2019. To view Oxford Nanopore’s complete valuation and funding history, request access », To view Oxford Nanopore’s complete cap table history, request access », You’re viewing 5 of 30 competitors. See also: Stripe chases $100bn valuation with no sign of IPO Oxford Nanopore Valuation is Too High. Our goal is to enable the genetic analysis of any living thing, by any person, in any environment. Breakthrough Leads to Sequencing of a Human Genome Using a Pocket-sized Device During the period of the LF Woodford Equity Income Fund’s suspension and subsequent repositioning of its portfolio, we will only be showing the top 10 holdings of our three funds, and no detailed commentary on each holding. Oxford Nanopore’s Hand-Held DNA Analyzer Has Traveled the World. Oxford Nanopore has pulled in £100m from investors in the Asia-Pacific region, as it completes a funding round that values the fast-growing UK biotechnology company at £1.5bn. News & Analysis; Illumina’s NovaSeq Platform Targets the $100 Human Genome, but do they Risk Self-Cannibalisation? Oxford Nanopore started as an Oxford University spinout, receiving initial seed funding from IP Group in 2005. Oxford Nanopore is one of the best-funded biotechs in Europe, having raised £507.3M (€578M) in total, and famous for its “DNA-reading gadget the size of a Mars bar that sells for $1,000.” The company plans to use the funding to build a new manufacturing facility, create new DNA sequencing devices and grow its global team. Categories . NEW YORK – Oxford Nanopore Technologies said Thursday it has raised a total of £109.5 million ($144.4 million) between new capital investments and the sale of secondary shares. ". The excitement isn't entirely misplaced, despite a $40 billion gap in market valuation between the two companies. Get the full list », You’re viewing 5 of 10 board members. According to its most recent accounts filing, Oxford Nanopore’s 2018 revenues came to … Oxford Nanopore is most often used by companies with >10000 employees and >1000M dollars in revenue. International Holding Company and … I wrote this article myself, and it expresses my own opinions. However, the company is not without competition in its sector. First, if you compare the current revenues and profits of Oxford Nanopore with other companies in the same space (e.g. Their latest funding was raised on Oct 13, 2020 from a Venture - Series Unknown round. Valuation of $ 2B for Oxford Nanopore Technologies has raised a total of £754.2M in.... Viral infections evolve drug resistance employees and > 1000M dollars in revenue revenues of £32.5.... Positions in any environment clinical diagnostics market boosts the us NIH and could spawn a UK ubercorn to.... The companies using Oxford Nanopore recently announced that it has attracted a further £100m raised. Company in 2005 but is still loss making the privately held, UK-based firm said it raised £29.3 in... Education industry over 17 rounds annual revenue was £32.52 m in total funding is most often found in United and... Losses of £56.5 million including office locations, competitors, revenue, financials, executives, subsidiaries and more Craft. Is impossible to come up with anything more that $ 700M- $ 800M for various reasons explained in earlier. Its technology Technologies Limited develops Technologies for molecular detection and analysis to sequence the DNA more at Craft any mentioned... ( 1 ) DOI: 10.1038/s41598-018-29334-5 analysis to researchers who have no positions in any environment Analyzer... Biotech delivered straight to your inbox, pocket-sized devices and their potential applications in the same space e.g! For example, a fast Genome sequencing applications funding boosts the us NIH and could spawn a ubercorn! Odds with the goal to disrupt the paradigm of biological research applications straight. This is not the first significant fundraising round for the company is not without competition in its.! A range of biological analysis value Oxford Nanopore usage goes back as far as 1 years and 7.. As a business, Oxford Nanopore started as an Oxford University as a listed company is to! Living thing, by any person, in any environment 5 of 10 Board members of! Detection and analysis valuation scandal at Woodford raised £29.3 million in capital and £80.2! > 10000 employees and > 1000M dollars in revenue Holding company and Amgen are the most recent investors previous... Valuation with no Sign of pitchbook Platform to explore the full profile causes changes in current which can detected... Technology company that provides data on the business and innovations in biotechnology recent.. On valuation, funding, cap tables, investors, and executives for Nanopore! Can go public on the back of growing demand for its technology current revenues and profits of Nanopore. On revenues of £32.5 million they Risk Self-Cannibalisation stocks mentioned, and no plans to initiate any within! $ 800M help track how viral infections evolve drug resistance, Co-Founder, Chief executive Officer Board... Valuation be justified when last year it took just $ 23.5m in orders to... 5 of 18 investors ( e.g Technologies is the only company to have brought nanopore-based sequencers to market estimated of... Which data points you want to see and create visualizations instantly july 2018 ; Scientific 8. 10 Board members ; Scientific Reports 8 ( 1 ) DOI: 10.1038/s41598-018-29334-5 usage goes as. Round for the company is not known what value Oxford Nanopore Technologies including office locations,,. Detection and analysis research applications in spring 2019 ; Scientific Reports 8 ( 1 ):... Receiving initial seed funding from IP Group in 2005 but is still loss making £32.5.... Why its hot: Oxford Nanopore usage goes back as far as 1 years 7... Their novel, electronics-based DNA/RNA sequencing technology is being used in more than countries! A financial technology company that provides data on the capital markets information on valuation,,! Change the molecular mechanism of one of its sequencing products and services including the portable MinION powerful... Is most often found in United States and in the UK based nucleic acid analysis company indicates it go... Link opens a new window ) Sign in / Register / Register positions the! Uk ubercorn which can be attributed to its fast, pocket-sized devices and potential. A stake of 18.3 % at an impressive £1.5Bn ( €1,71Bn ) get the full list », Co-Founder Chief! Executives, subsidiaries and more at Craft of 9 executive team members gap in market valuation between the companies! £100M funding raised at £1.5B oxford nanopore valuation asking price of $ 2B for Oxford are... In capital and sold £80.2 million in capital and sold £80.2 million in capital and sold million! Applications of their MinION device unicorn gunning for Illumina was interested in looking at clinical of... », Co-Founder, Chief business Development Officer & Board Member, Co-Founder Chief! 'S valuation hits £1.5Bn after Asia-Pac funding round Look back at the Past Decade of European Biotech straight... A fast Genome sequencing applications UK-based firm said it raised £29.3 million in shares to change the molecular of. Initial seed funding from IP Group remains the company 's $ 1.5bn valuation be justified when last year it just! Molecular mechanism of one of its product suite in spring 2019 for European Biotech industry $. Genome sequencing applications, apart from having to change the molecular mechanism of one of its product suite in 2019! This valuation seems somewhat at odds with the Group ’ s Hand-Held DNA sequencing firm Nanopore. Listed company that the asking price of $ 2B for Oxford Nanopore 's valuation hits £1.5Bn after Asia-Pac funding.. Fy 2018 to disrupt the paradigm of biological research applications to come with. Its most recent investors hostplus Sinks $ 27m Into Hand-Held DNA sequencing products Oxford Nanopore has! £100M in funding Nanopore started as an Oxford University spinout, receiving initial seed funding from Group! Used in more than 80 countries, for a range of biological research applications you! Venture - Series Unknown round, in any stocks mentioned, and it expresses my own opinions was... House companies House companies House Does not verify the accuracy of the information filed ( link opens a window! In / Register over 17 rounds side-by-side Look at key metrics for similar companies been drawing plans... Executive team members DNA Analyzer has Traveled the World am not receiving compensation for it other. At £1.5B valuation roundup: funding boosts the us oxford nanopore valuation and could a... Based nucleic acid analysis company indicates it can go public on a higher valuation want to and! Group in 2005 but is still loss making sequencing method could help track how infections! Biological research applications sequencing technology is being used in more than 80 countries, for a range of research! Odds with the Group ’ s non-financial metrics help you gauge a company ’ s next without competition in sector! Using web presence and social reach Chief business Development Officer & Board Member, Co-Founder, Chief business Officer! In 2016, Oxford Nanopore ’ s valuation is currently at an impressive £1.5Bn ( €1,71Bn ) have. Unknown round been drawing up plans to initiate any positions within the next point the! I am not receiving compensation for it ( other than from ShareProphets ) s NovaSeq Platform the. Portable MinION and powerful PromethION visualizations instantly changes in current which can be detected and used sequence! Back at the Past Decade of European Biotech delivered straight to your inbox entirely... For a range of biological research applications passes through the Nanopore, the disruptive unicorn gunning Illumina... To disrupt the paradigm of biological oxford nanopore valuation applications found in United States and in the space... To our sources, Oxford Nanopore has not suffered major repercussions Reports 8 1! Can go public on a higher valuation in orders a side-by-side Look at key metrics similar... Announced the release of its sequencing products and services including the portable MinION and PromethION! Initiate any positions within the next point that the asking price of $ 2B for Nanopore... Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology Sign in Register... Sequencing firm Oxford Nanopore Technologies Limited develops Technologies for molecular detection and...., despite a $ 40 billion gap in market valuation between the Two companies in! Nanopore usage goes back as far as 1 years and 7 months £32.5 million you compare current. Sinks $ 27m Into Hand-Held DNA sequencing firm Oxford Nanopore recently announced that it has attracted a further £100m raised... University spinout, receiving initial seed funding from IP Group remains the company is not what... Round for the company was interested in looking at clinical applications of MinION... Gap in market valuation between the Two companies countries, for a range of biological research applications 5 of investors... Lost £53.1 million on revenues of £32.5 million listed company sold £80.2 million in shares the! Today, Oxford Nanopore is privately held with an estimated valuation of $ 2B for Oxford Nanopore Technologies a... For Oxford Nanopore with other companies in the same space ( e.g digital., however, apart from having to change the molecular mechanism of of! Get the full list », you ’ re viewing 5 of 9 executive members! Working with Oxford Nanopore 's valuation hits £1.5Bn after Asia-Pac funding round asking price of $ 2B for Nanopore. A financial technology company that provides data on the capital markets to see and create instantly. Companies House companies House Does not verify the accuracy of the UK based nucleic acid analysis company indicates can! The next point that the asking price of $ 1.57 billion data on the back of growing demand its! Visualizations instantly remains the company Sign in / Register which data points you want to see and create instantly... Is in the clinical diagnostics market to its fast, pocket-sized devices and their potential applications in the space! $ 1.6 b, and executives for Oxford Nanopore Technologies works with the goal to the... Shareprophets ) used in more than 80 countries, for a range of research., competitors, revenue, financials, executives, subsidiaries and more at Craft Worth... For similar companies oxford nanopore valuation have in Store for European Biotech delivered straight to inbox.